PLA2G4A

PLA2G4A
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesPLA2G4A, PLA2G4, cPLA2-alpha, cPLA2, phospholipase A2 group IVA
External IDsMGI: 1195256 HomoloGene: 32059 GeneCards: PLA2G4A
Gene location (Human)
Chr.Chromosome 1 (human)[1]
Band1q31.1Start186,828,953 bp[1]
End186,988,981 bp[1]
RNA expression pattern
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez

5321

18783

Ensembl

ENSG00000116711

ENSMUSG00000056220

UniProt

P47712

P47713

RefSeq (mRNA)

NM_001311193
NM_024420

NM_008869
NM_001305632

RefSeq (protein)

NP_001298122
NP_077734

NP_001292561
NP_032895

Location (UCSC)Chr 1: 186.83 – 186.99 MbChr 1: 149.83 – 149.96 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Cytosolic phospholipase A2 is an enzyme that in humans is encoded by the PLA2G4A gene.[5][6]

Function

This gene encodes a member of the cytosolic phospholipase A2 group IV family. The enzyme catalyzes the hydrolysis of membrane phospholipids to release arachidonic acid which is subsequently metabolized into eicosanoids. Eicosanoids, including prostaglandins and leukotrienes, are lipid-based cellular hormones that regulate hemodynamics, inflammatory responses, and other intracellular pathways. The hydrolysis reaction also produces lysophospholipids that are converted into platelet-activating factor. The enzyme is activated by increased intracellular Ca2+ levels and phosphorylation, resulting in its translocation from the cytosol and nucleus to perinuclear membrane vesicles.[6]

Interactions

PLA2G4A has been shown to interact with HTATIP.[7]

Clinical significance

Mutations in this gene have been associated with multifocal stenosing ulceration of the small intestine.[8]

References

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000116711 - Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000056220 - Ensembl, May 2017
  3. ↑ "Human PubMed Reference:".
  4. ↑ "Mouse PubMed Reference:".
  5. ↑ Dennis EA (Jun 1994). "Diversity of group types, regulation, and function of phospholipase A2". Journal of Biological Chemistry. 269 (18): 13057–13060. PMID 8175726.
  6. 1 2 "Entrez Gene: PLA2G4A phospholipase A2, group IVA (cytosolic, calcium-dependent)".
  7. ↑ Sheridan AM, Force T, Yoon HJ, O'Leary E, Choukroun G, Taheri MR, Bonventre JV (July 2001). "PLIP, a novel splice variant of Tip60, interacts with group IV cytosolic phospholipase A(2), induces apoptosis, and potentiates prostaglandin production". Molecular and Cellular Biology. 21 (14): 4470–4481. doi:10.1128/MCB.21.14.4470-4481.2001. PMC 87107. PMID 11416127.
  8. ↑ Brooke MA, Longhurst HJ, Plagnol V, Kirkby NS, Mitchell JA, Rüschendorf F, Warner TD, Kelsell DP, Macdonald TT (December 2012). "Cryptogenic multifocal ulcerating stenosing enteritis associated with homozygous deletion mutations in cytosolic phospholipase A2-α". Gut. 63: 96–104. doi:10.1136/gutjnl-2012-303581. PMID 23268370.

Further reading

  • Schröder HC, Perovic S, Kavsan V, et al. (1998). "Mechanisms of prionSc- and HIV-1 gp120 induced neuronal cell death". Neurotoxicology. 19 (4–5): 683–688. PMID 9745929.
  • Hirabayashi T, Murayama T, Shimizu T (2005). "Regulatory mechanism and physiological role of cytosolic phospholipase A2". Biological and Pharmaceutical Bulletin. 27 (8): 1168–1173. doi:10.1248/bpb.27.1168. PMID 15305015.
  • Law MH, Cotton RG, Berger GE (2006). "The role of phospholipases A2 in schizophrenia". Molecular Psychiatry. 11 (6): 547–556. doi:10.1038/sj.mp.4001819. PMID 16585943.
  • Shimizu T, Ohto T, Kita Y (2006). "Cytosolic phospholipase A2: biochemical properties and physiological roles". IUBMB Life. 58 (5–6): 328–333. doi:10.1080/15216540600702289. PMID 16754327.
  • Sharp JD, White DL, Chiou XG, et al. (1991). "Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2". Journal of Biological Chemistry. 266 (23): 14850–14853. PMID 1869522.
  • Clark JD, Lin LL, Kriz RW, et al. (1991). "A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP". Cell. 65 (6): 1043–1051. doi:10.1016/0092-8674(91)90556-E. PMID 1904318.
  • Tay A, Simon JS, Squire J, et al. (1995). "Cytosolic phospholipase A2 gene in human and rat: chromosomal localization and polymorphic markers". Genomics. 26 (1): 138–141. doi:10.1016/0888-7543(95)80093-2. PMID 7782073.
  • Wu T, Ikezono T, Angus CW, Shelhamer JH (1995). "Characterization of the promoter for the human 85 kDa cytosolic phospholipase A2 gene". Nucleic Acids Research. 22 (23): 5093–5098. doi:10.1093/nar/22.23.5093. PMC 523783. PMID 7800505.
  • Miyashita A, Crystal RG, Hay JG (1995). "Identification of a 27 bp 5'-flanking region element responsible for the low level constitutive expression of the human cytosolic phospholipase A2 gene". Nucleic Acids Research. 23 (2): 293–301. doi:10.1093/nar/23.2.293. PMC 306668. PMID 7862535.
  • Morri H, Ozaki M, Watanabe Y (1995). "5'-flanking region surrounding a human cytosolic phospholipase A2 gene". Biochemical and Biophysical Research Communications. 205 (1): 6–11. doi:10.1006/bbrc.1994.2621. PMID 7999086.
  • Sharp JD, Pickard RT, Chiou XG, et al. (1994). "Serine 228 is essential for catalytic activities of 85-kDa cytosolic phospholipase A2". Journal of Biological Chemistry. 269 (37): 23250–23254. PMID 8083230.
  • Lin LL, Wartmann M, Lin AY, et al. (1993). "cPLA2 is phosphorylated and activated by MAP kinase". Cell. 72 (2): 269–78. doi:10.1016/0092-8674(93)90666-E. PMID 8381049.
  • Flati V, Haque SJ, Williams BR (1996). "Interferon-alpha-induced phosphorylation and activation of cytosolic phospholipase A2 is required for the formation of interferon-stimulated gene factor three". EMBO Journal. 15 (7): 1566–1571. PMC 450066. PMID 8612580.
  • de Carvalho MG, McCormack AL, Olson E, et al. (1996). "Identification of phosphorylation sites of human 85-kDa cytosolic phospholipase A2 expressed in insect cells and present in human monocytes". Journal of Biological Chemistry. 271 (12): 6987–6997. doi:10.1074/jbc.271.12.6987. PMID 8636128.
  • Freed KA, Moses EK, Brennecke SP, Rice GE (1997). "Differential expression of type II, IV and cytosolic PLA2 messenger RNA in human intrauterine tissues at term". Molecular Human Reproduction. 3 (6): 493–499. doi:10.1093/molehr/3.6.493. PMID 9239738.
  • Mavoungou E, Georges-Courbot MC, Poaty-Mavoungou V, et al. (1997). "HIV and SIV envelope glycoproteins induce phospholipase A2 activation in human and macaque lymphocytes". Journal of the Acquired Immune Deficiency Syndrome and Human Retrovirology. 16 (1): 1–9. doi:10.1097/00042560-199709010-00001. PMID 9377118.
  • Perisic O, Fong S, Lynch DE, et al. (1998). "Crystal structure of a calcium-phospholipid binding domain from cytosolic phospholipase A2". Journal of Biological Chemistry. 273 (3): 1596–1604. doi:10.1074/jbc.273.3.1596. PMID 9430701.
  • Börsch-Haubold AG, Bartoli F, Asselin J, et al. (1998). "Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells". Journal of Biological Chemistry. 273 (8): 4449–4458. doi:10.1074/jbc.273.8.4449. PMID 9468497.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.